title: [The effect of HPV16E7 DNA vaccine transdermal delivery with microneedle array].
abstract: OBJECTIVE
  To study the effects of DNA vaccine transdermal delivery with microneedle array.
  
  
  METHODS
  The pcDNA3.1-HPV16E7 recombinant vector acting as gene vaccine was established. The infiltration quantity of pcDNA3.1-HPV16E7 getting across the microchannels generated by microneedle arrays in vitro was observed. 30 BALB/c mice were divided into 3 groups (experimental group, in vain plasmid group, negative control). Each group had 10 mice. Then immunized BALB/c mice with a dose of 200 microg with microneedle array every two weeks. The control groups did the same as that as the study groups. Two weeks after the third immunization, the serum and lymphocytes were separated to detect the functions of humoral immunity with indirect immunofluorescence test, while, the functions of cellular immunity with lymphocyte transformation test was also detected.
  
  
  RESULTS
  The DNA vaccine could easily get across the microchannels generated by microneedle arrays in vitro. Moreover, the course was permanent and the whole infiltration quantity was comparatively high, reaching 0.73819 mg/cm2 at the 30th hour. And among immunized BALB/c mouse, DNA vaccine transdermal delivery with microneedle array could induce specific antibodies. Lymphocyte transformation test showed that there was significant difference for the lymphocyte transformation rate between experiment (the average of lymphocyte transformation rate was 47.25%) and control group (the average of lymphocyte transformation rate was 30.00%) (chi2 = 12.903, P < 0.001). Also, the difference was found between in vain plasmid group (the average of lymphocyte transformation rate was 43.00%) and negative control(chi2 = 7.292, P = 0.007). While, no difference was observed in the experimental group and in vain plasmid group (chi2 = 0.817, P = 0.366).
  
  
  CONCLUSIONS
  The DNA vaccine combined administering with microneedle array might get across the microchannels generated by microneedle arrays in vitro and induce humoral and cellular immune response in vivo.
authors.affiliation: Dermatology Department of Clinical Medical College, Yangzhou University, Yangzhou 225001, China.
authors.forename: Hui
authors.initials: H
authors.lastname: Gao
authors.forename: Jin-Chun
authors.initials: JC
authors.lastname: Pan
authors.forename: Bing
authors.initials: B
authors.lastname: Chen
authors.forename: Zheng-Feng
authors.initials: ZF
authors.lastname: Xue
authors.forename: Hou-Da
authors.initials: HD
authors.lastname: Li
mesh_terms: D000279:Administration, Cutaneous; D000818:Animals; D052162:Human papillomavirus 16 / Q000235:genetics / Q000276:immunology; D007267:Injections; D051379:Mice; D008807:Mice, Inbred BALB C; D012869:Skin Absorption; D019444:Vaccines, DNA / Q000008:administration & dosage* / Q000276:immunology
chemical_list: D019444:Vaccines, DNA